Nuclear Medicine
CLINICAL DECISION SUPPORT
| Clinical Evaluation |
|---|
| Expression of prostate specific membrane antigen |
| Type of Imaging |
| PET |
| Grade of Recommendation |
| A (strongly recommended) |
| Level of Evidence |
| well-established clinical and NM recommendations recommendations |
| Effective Dose |
| 20.0 µSv/MBq |
| Bibliographic Reference |
|
NCCN guideline https://www.nccn.org/guidelines/nccn-guidelines, EAU guideline, Mottet, N., van den Bergh, R.C.N., Briers, E., Van den Broeck, T., Cumb...
read more
NCCN guideline https://www.nccn.org/guidelines/nccn-guidelines, EAU guideline, Mottet, N., van den Bergh, R.C.N., Briers, E., Van den Broeck, T., Cumberbatch, M.G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., Grivas, N., Grummet, J., Henry, A.M., van der Kwast, T.H., Lam, T.B., Lardas, M., Liew, M., Mason, MD., Moris, L., Oprea-Lager, D.E., van der Poel, H.G., Rouvière, O., Schoots, I.G., Tilki, D., Wiegel, T., Willemse, P.M., Cornford, P. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021; https://doi.org/10.1016/j.eururo.2020.09.042
read less
|
| Guide to Nuclear Medicine |
| Read the corresponding chapter |